Literature DB >> 10382908

Correlation of muscle fiber type measurements with clinical and molecular genetic data in Duchenne muscular dystrophy.

J F Wang1, J Forst, S Schröder, J M Schröder.   

Abstract

Clinical improvement following surgery in patients with Duchenne muscular dystrophy (DMD) may be influenced by the severity of muscle fiber damage. This study correlates morphometric alterations of muscle fiber types, severity of fat tissue proliferation and fibrosis with Western blots, multiplex polymerase chain reaction (PCR), and postoperative state in DMD. The main results of this study show that the mean diameter of type 2 fibers is usually markedly larger than that of type I fibers in DMD although the number of type 2 fibers is severely reduced. The mean percentage of the remaining type 1 fibers was in the range of 57-82%. The morphometric and histopathological results were in agreement with the clinically estimated postoperative state, especially in the patients who presented a severe state or suggestive clinical improvement. It is concluded that combination of both quantitative and qualitative evaluation of muscle biopsies is suitable for better evaluation of the postoperative state in patients with DMD, whereas severity of exon deletions correlated poorly with morphometry and postoperative clinical state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382908     DOI: 10.1016/s0960-8966(98)00114-x

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  A Rapid Automated Protocol for Muscle Fiber Population Analysis in Rat Muscle Cross Sections Using Myosin Heavy Chain Immunohistochemistry.

Authors:  Konstantin D Bergmeister; Marion Gröger; Martin Aman; Anna Willensdorfer; Krisztina Manzano-Szalai; Stefan Salminger; Oskar C Aszmann
Journal:  J Vis Exp       Date:  2017-03-28       Impact factor: 1.355

2.  Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy.

Authors:  Ning Liu; Svetlana Bezprozvannaya; John M Shelton; Madlyn I Frisard; Matthew W Hulver; Ryan P McMillan; Yaru Wu; Kevin A Voelker; Robert W Grange; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

3.  MyoVision: software for automated high-content analysis of skeletal muscle immunohistochemistry.

Authors:  Yuan Wen; Kevin A Murach; Ivan J Vechetti; Christopher S Fry; Chase Vickery; Charlotte A Peterson; John J McCarthy; Kenneth S Campbell
Journal:  J Appl Physiol (1985)       Date:  2017-10-05

4.  Muscular dystrophy in PTFR/cavin-1 null mice.

Authors:  Shi-Ying Ding; Libin Liu; Paul F Pilch
Journal:  JCI Insight       Date:  2017-03-09

5.  Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study.

Authors:  Cristina Chimenti; Luca Padua; Costanza Pazzaglia; Emanuela Morgante; Carlos Centurion; Daniela Antuzzi; Matteo A Russo; Andrea Frustaci
Journal:  Hum Pathol       Date:  2012-03-08       Impact factor: 3.466

6.  Abnormal Skeletal Muscle Regeneration plus Mild Alterations in Mature Fiber Type Specification in Fktn-Deficient Dystroglycanopathy Muscular Dystrophy Mice.

Authors:  Steven J Foltz; Jill N Modi; Garrett A Melick; Marin I Abousaud; Junna Luan; Marisa J Fortunato; Aaron M Beedle
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.